XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net income $ 327,262 $ 8,817
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 94,567 80,874
Depreciation 253,846 271,341
ESOP compensation expense 168,318 56,274
Deferred income tax benefit (33,908) (35,524)
Changes in assets and liabilities:    
Decrease in trade accounts receivable 465,382 4,805,803
Increase in income taxes receivable (3,041) (86,274)
Increase in ESOP receivable due to dividends on unallocated shares (18,726)
Increase in inventories (537,319) (1,706,735)
Increase in prepaid expenses and other current assets (108,560) (109,615)
(Decrease) increase in accounts payable (132,999) 392,287
Increase (decrease) in accrued salaries and wages 173,422 (125,060)
Decrease in vacation accrual (16,319) (23,674)
Decrease in ESOP Payable (56,274)
Decrease in other accrued expenses (68,977) (228,136)
(Decrease) increase in payroll and other taxes withheld (130,957) 276,315
Decrease in contract liabilities (172,859) (524,947)
Decrease in income taxes payable (47,707)
Net cash provided by operating activities 277,858 2,929,039
Cash Flows from Investing Activities:    
Additions to property, plant and equipment (97,288) (29,173)
Purchase of investment securities (2,061,000) (2,391,686)
Proceeds from sale/maturity of investment securities 2,096,000 4,331,407
Net cash (used in) provided by investing activities (62,288) 1,910,548
Cash Flows from Financing Activities:    
Dividends on common stock (1,201,316)
Net cash used in financing activities (1,201,316)
Increase in cash and cash equivalents 215,570 3,638,271
Cash and cash equivalents, beginning of period 6,802,712 5,402,122
Cash and cash equivalents, end of period 7,018,282 9,040,393
Supplemental Schedule of Cash Flow Information:    
Income taxes paid $ 120,000 $ 175,250